Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10814007 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Patent 10814007 was granted and assigned to Alnylam Pharmaceuticals on October, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834661 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
Edits on 18 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1081400700
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 3 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Current Assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
108140070
Date of Patent
October 27, 2020
0
Patent Application Number
162743930
Date Filed
February 13, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=108140070
Patent Citations
‌
US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
Patent Primary Examiner
‌
Terra C Gibbs
0
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Current Assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
108140070
Date of Patent
October 27, 2020
0
Patent Application Number
162743930
Date Filed
February 13, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=108140070
Patent Citations
‌
US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
Patent Primary Examiner
‌
Terra C Gibbs
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10814007
Edits on 7 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Feb, 2022
Edits made to:
Infobox (+10 properties)
‌

 US Patent 10814007 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Infobox
Is a
Patent
Patent
Patent applicant
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Current assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10814007
Date of patent
October 27, 2020
Patent application number
16274393
Date Filed
February 13, 2019
Patent citations
‌
US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Patent primary examiner
‌
Terra C Gibbs

Find more entities like US Patent 10814007 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo